|
Screen positivity (%, 95%CI)
|
4879 (3.1)
|
23 764 (9.6)
|
3.40 (3.29–3.51)
|
8345 (4.9)
|
60 827 (10.4)
|
2.27 (2.21–2.32)
|
|
Per protocol colposcopy referral (%, 95%CI)a
|
4879 (3.1)
|
9050 (3.7)
|
1.21 (1.17–1.25)
|
8345 (4.9)
|
19 982 (3.4)
|
0.69 (0.67–0.71)
|
|
Overall colposcopy referral (%, 95%CI)
|
4206 (2.7)
|
9721 (3.9)
|
1.55 (1.50–1.61)
|
8106 (4.8)
|
23 346 (4.0)
|
0.83 (0.80–0.85)
|
|
Per protocol detection rate of CIN or cancer (per 1000, 95%CI)
|
|
CIN2+
|
406 (3.0)
|
993 (4.7)
|
1.53 (1.37–1.70)
|
816 (5.6)
|
2867 (5.7)
|
1.03 (0.96–1.11)
|
|
CIN2 or 3
|
368 (2.7)
|
912 (4.3)
|
1.55 (1.38–1.73)
|
757 (5.2)
|
2611 (5.2)
|
1.01 (0.94–1.09)
|
|
Invasive cervical cancer
|
38 (0.3)
|
81 (0.4)
|
1.32 (0.92–1.89)
|
59 (0.4)
|
256 (0.5)
|
1.32 (1.02–1.71)
|
|
Overall detection rate of CIN or cancer b (per 1000, 95%CI)
|
|
CIN2+
|
417 (3.1)
|
1039 (4.9)
|
1.56 (1.40–1.73)
|
885 (6.0)
|
3060 (6.1)
|
1.01 (0.95–1.09)
|
|
CIN2 or 3
|
373 (2.8)
|
938 (4.4)
|
1.57 (1.41–1.76)
|
798 (5.5)
|
2760 (5.5)
|
1.01 (0.94–1.09)
|
|
Invasive cervical cancer
|
44 (0.3)
|
101 (0.5)
|
1.44 (1.03–2.01)
|
87 (0.6)
|
300 (0.6)
|
1.08 (0.86–1.35)
|
|
Positive predictive value c (%, 95%CI)
|
|
CIN2+
|
406 (9.9)
|
1018 (12.4)
|
1.23 (1.10–1.38)
|
816 (11.4)
|
3012 (14.3)
|
1.31 (1.21–1.41)
|
|
CIN2 or 3
|
368 (9.0)
|
936 (11.4)
|
1.25 (1.11–1.40)
|
757 (10.6)
|
2732 (13.0)
|
1.27 (1.17–1.38)
|
|
Invasive cervical cancer
|
38 (0.9)
|
82 (1.0)
|
1.02 (0.71–1.46)
|
59 (0.8)
|
280 (1.3)
|
1.65 (1.27–2.14)
|
